Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphoma

British Journal of Haematology

Volumn 109, Issue 3, 2000, Pages 592-599

  Inaba, Tohru ^a   Shimazaki, Chihiro ^a   Sumikuma, Toshiya ^a   Okano, Akira ^a   Hatsuse, Mayumi ^a   Okamoto, Akio ^a   Takahashi, Ryoichi ^a   Ashihara, Eishi ^a   Hibi, Shigeyoshi ^a   Sudo, Yoshikazu ^b   Yamagata, Noboru ^c   Murakami, Satoshi ^d   Rin, Kenhiro ^e   Fujita, Naohisa ^a   Yoshimura, Manabu ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Ohmihachiman City Hospital   (Japan)

^c NANTAN GENERAL HOSPITAL   (Japan)

^d Shakai Hoken Kyoto Hospital   (Japan)

^e Akashi Municipal Hospital   (Japan)

Author keywords

B cell non Hodgkin's lymphoma; Extranodal involvement; T cell associated antigens; Two colour flow cytometry

Indexed keywords

CD2 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPH NODE; LYMPHOMA CELL; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS; ANTIGENS, CD2; ANTIGENS, CD5; ANTIGENS, CD7; BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 0034122664     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02006.x     Document Type: Article

References (24)

1. Bosch, F., Jares, P., Campo, E., Lopez, G.A., Piris, M.A., Villamor, N., Tassies, D., Jaffe, E.S., Montserrat, E., Rozman, C. & Cardesa, A. (1994) PRAD-1/Cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood, 84, 2726-2732.
2. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. & Tubiana, M. (1977) Report of the committee on Hodgkin's disease staging classification. Cancer Research, 31, 1860-1861.
3. Cousar, J.B. (1995) Surgical pathology examination of lymph nodes. American Journal of Clinical Pathology, 104, 126-132.
4. Guglielmi, C., Martelli, M.P., Diverio, D., Fenu, S., Vegna, M.L., Rajnoldi, A.C., Biondi, A., Cocito, M.G., Vecchio, L.D., Tabilio, A., Avvisati, G., Basso, G. & Coco, F.L. (1998) Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. British Journal of Haematology, 102, 1035-1041.
5. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., Wolf-Peeters, C.D., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.K., Pileri, S.A., Piris, M.A., Ralfkiaer, E. & Warnke, R.A. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood, 84, 1361-1392.
6. Ichinohasama, R., DeCoteau, J.F., Myers, J., Kadin, M.E., Sawai, T. & Ooya, K. (1997) Three-color flow cytometry in the diagnosis of malignant lymphoma based on the comparative cell morphology of lymphoma cells and reactive lymphocytes. Leukemia, 11, 1891-1903.
7. Jennings, C.D. & Foon, K.A. (1997) Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood, 90, 2863-2892.
8. Kita, K., Miwa, H., Nakase, K., Kawakami, K., Kobayashi, T., Shirakawa, S., Tanaka, I., Ohta, C., Tsutani, H., Oguma, S., Kyo, T., Dohy, H., Kamada, N., Nasu, K. & Uchino, H. (1993) Clinical importance of CD7 expression in acute myelocytic leukemia. Blood, 81, 2399-2405.
9. Kume, M., Suzuki, R., Yatabe, Y., Kagami, Y., Miura, I., Miura, A.B., Morishima, Y., Nakamura, S. & Seto, M. (1997) Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphoma. Japanese Journal of Cancer Research, 88, 1087-1093.
10. Matolcsy, A., Chadburn, A. & Knowles, D.M. (1995) De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. American Journal of Pathology, 147, 207-216.
11. Mills, K., Worman, C. & Cawley, J. (1983) Normal human B cells express endogenous sheep erythrocyte (E) receptor after appropriate in vitro culture. European Journal of Immunology, 13, 379-382.
12. Norton, A.J. & Isaacson, P.G. (1987) Detailed phenotypic analysis of 13-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue. American Journal of Pathology, 128, 225-240.
13. Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T. & Carbone, P.P. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5, 649-655.
14. Picker, L.J., Weiss, L.M., Medeiros, L.J., Wood, G.S. & Warnke, R.A. (1987) Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. American Journal of Pathology, 128, 181-201.
15. Rosenberg, S.A. (1982) National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer, 49, 2112-2135.
16. Schuurman, H.J., van Baarlen, J., Huppes, W., Lam, B.W., Verdonck, L.F. & van Unnik, J.A.M. (1987) Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology. Amrican Journal of Pathology, 129, 140-151.
17. Shimazaki, C., Inaba, T., Shimura, K., Okamoto, A., Takahashi, R., Hirai, H., Sudo, Y., Ashihara, E., Adachi, Y. Murakami, S., Saigo, K., Fujita, N. & Nakagawa, M. (1999) B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. British Journal of Haematology, 104, 672-679.
18. Southern, E.M. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology, 98, 503-517.
19. Spier, C.M., Grogan, T.M., Lippman, S.M., Slymen, D.S., Rybski, J.A. & Miller, T.P. (1988) The aberrancy on immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma. American Journal of Pathology, 133, 118-126.
20. Taniguchi, M., Oka, K., Hiasa, A., Yamaguchi, M., Ohno, T., Kita, K. & Shiku, H. (1998) De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood, 91, 1145-1151.
21. Tbakhi, A., Edinger, M., Myles. J., Pohlman, B. & Tubbs, R.R. (1996) Flow cytometric immunophenotyping of non-Hodgkin's lymphoma and related disorders. Cytometry, 25, 113-124.
22. The International non-Hodgkin's Lymphoma Prognostic Factor Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine, 329, 987-994.
23. Viciana, A.L., Lancet, F.C., Chamizo, W, Voigt, W. & Ruiz, P. (1994) Simultaneous expression of CD2 on B-cell, small lymphocytic neoplasm. Cytometry, 18, 42-48.
24. Yatabe, Y., Nakamura, S., Seto, M., Kuroda, H., Kagami, Y., Suzuki, R., Ogura, M., Kojima, M., Koshikawa, T., Ueda, R. & Suchi, T. (1996) Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity. American Journal of Surgical Pathology, 20, 1110-1122.